This Anti-Aging Drug is Disrupting a $600 Billion Industry
Dr. Alan Kaplin, Chief Scientific Officer of MyMD, joins Cheddar Innovates to discuss how the MYMD-1 is on track to be the first FDA-approved drug to treat aging and age-related diseases.
More Videos
How Kim Perell Turned Mistakes into Millions
Entrepreneur & author Kim Perell shares lessons from 'Mistakes That Made Me a Millionaire', revealing how failure was the key to building her success.
Go Fund Yourself: Ready To Level Up Your Health and Home?
Flexicon's resistance band system brings gym-level results without joint strain, while Pathogenix.ai's smart air monitor detects invisible threats in minutes.
From Trade Tensions to Rate Cuts: What’s Driving the Market Now?
Mark Hackett, Chief Market Strategist at Nationwide, shares insight on market sentiment, Fed policy impact, and the outlook amid trade tensions.
Crypto 401(k)s Explained: Maple CEO Sid Powell on the Staking Revolution
Sid Powell, CEO of Maple Finance, demystifies crypto 401(k)s and explains how staking lets users earn passive yield while supporting decentralization.
Bullish IPO Soars: An Inside View with President Chris Tyrer
Chris Tyrer, President at Bullish (NYSE: BLSH), reveals how the IPO-fueled rise of the company is redefining institutional crypto markets.
OpenAI’s GPT‑5 Sparks Hype — But Users Say It’s a Mixed Bag
Rebecca Bellan, Senior Reporter at TechCrunch, dives into ChatGPT’s GPT‑5 release—what’s new, what’s controversial, and why this model could change the game.
